PPARG and Hyperglycemia: Pegg et al. (2013) provided further evidence which demonstrated that using EGFR inhibitor with a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist attenuates the fibrosis and inflammation resulting from hyperglycemia.